WEBULL
News
CASI
0.8102
-10.48%
-0.0948
BRIEF-Casi Pharmaceuticals Reports The Receipt Of Drug Registration Certificate For Thiotepa In China
Reuters · 16h ago
CASI Pharmaceuticals Secures China Drug Registration for Thiotepa Ahead of Planned Asset Disposal
TipRanks · 17h ago
CASI Pharmaceuticals Receives Drug Registration Certificate for Thiotepa in China
Reuters · 17h ago
Weekly Report: what happened at CASI last week (0202-0206)?
Weekly Report · 1d ago
Weekly Report: what happened at CASI last week (0126-0130)?
Weekly Report · 02/02 10:32
Weekly Report: what happened at CASI last week (0119-0123)?
Weekly Report · 01/26 10:32
CASI Pharmaceuticals Fails To Renew FOLOTYN Import License In China, Halting Sales
Benzinga · 01/22 14:07
Weekly Report: what happened at CASI last week (0112-0116)?
Weekly Report · 01/19 10:39
Casi Pharmaceuticals announces NMPA approval of CTA for Phase 1/2 CID-103 study
TipRanks · 01/15 14:15
CASI Pharmaceuticals Gets China National Medical Products Administration's Approval To Start Phase1/2 Clinical Study For CID-103 In Adults With Chronic Active Renal Allograft Antibody-Mediated Rejection
Benzinga · 01/15 14:05
CASI Pharmaceuticals Receives China NMPA Approval for Phase 1/2 Clinical Trial of CID-103 in Renal Allograft AMR
Reuters · 01/15 14:00
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 01/14 21:06
CASI Pharmaceuticals Closes Second Tranche of US$20 Million Convertible Note Financing
TipRanks · 01/13 14:40
Casi Pharmaceuticals announces results from Phase 1 study of CID-103
TipRanks · 01/12 14:45
CASI Pharmaceuticals Reports 80% Efficacy in Phase 1 Study of CID-103 for Immune Thrombocytopenia
Reuters · 01/12 14:01
Weekly Report: what happened at CASI last week (0105-0109)?
Weekly Report · 01/12 10:38
Weekly Report: what happened at CASI last week (1229-0102)?
Weekly Report · 01/05 10:31
CASI Pharmaceuticals Closes First US$5 Million Tranche of Convertible Note Financing
TipRanks · 12/31/2025 11:30
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 12/30/2025 12:05
Weekly Report: what happened at CASI last week (1222-1226)?
Weekly Report · 12/29/2025 10:30
More
Webull provides a variety of real-time CASI stock news. You can receive the latest news about Casi Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About CASI
CASI Pharmaceuticals Inc is a holding company principally engaged in developing and commercializing innovative therapeutics and pharmaceutical products. The Company’s main business is engaged in acquiring, developing and commercializing products that augment its hematology oncology, autoimmune and organ transplant rejection therapeutic area focus as well as other unmet medical need. The Company’s main products include EVOMELA (Melphalan for Injection), FOLOTYN (Pralatrexate), CNCT19, BI-1206, CB-5339, CID-103, Thiotepa and others. The Company mainly conducts its business in the domestic market.